Carcinoid tumors of the lung: Immuno- and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically

Journal of Surgical Oncology

Volumn 63, Issue 2, 1996, Pages 99-106

  Kayser, Klaus ^a   Kayser, Corinna ^a   Rahn, Wolfgang ^b   Bovin, Nicolai V ^d   Gabius, Hans Joachim ^c  

^a Thoraxklinik ^*  (Germany)

^b Klinik Heckeshorn   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

lectin; lymphokine; neoglycoconjugate; p53; prognosis

Indexed keywords

LIGAND; MACROPHAGE MIGRATION INHIBITION FACTOR; N ACETYLGALACTOSAMINE;

ARTICLE; CANCER SURVIVAL; CARCINOID; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; LUNG RESECTION; LUNG TUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; PRIORITY JOURNAL; PROGNOSIS; STRUCTURE ANALYSIS;

ADOLESCENT; ADULT; AGED; CARCINOID TUMOR; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0029911353     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199610)63:2<99::AID-JSO6>3.0.CO;2-J     Document Type: Article

References (45)

1. Kayser K. Analytical Lung Pathology. Heidelberg: Springer, 1992.
2. Colby TV, Koss MN, Travis WD: Tumors of the lower respiratory tract. In: "Atlas of Tumor Pathology." Washington, DC: AFIP, 1995.
3. Totsch M, Padberg PC, Schroder S, et al.: Secretoneurin in bronchopulmonary carcinoids-immunohistochemical comparison with chromogranin A and B and secretogranin II. Histopathology 26:357-361, 1995.
4. Capella C, Heitz PU, Hofler H, et al.: Revised classification of neuroendocrine tumors of the lung, pancreas and gut. Digestion 55(Suppl 3):11-23, 1994.
5. Jacobsen MB, Nitter-Hauge S, Bryde PE, Hansen LE: Cardiac manifestations in mid-gut carcinoid disease. Eur Heart J 16:263-268, 1995.
6. Stridsberg M, Erikson B, Lundqvist G, et al.: Islet amyloid polypeptide in patients with neuroendocrine tumors. Regul Pept 55:119-131, 1995.
7. Liu HR, Liu TH, Lu ZL: Pathological study of thoracic carcinoids accompanied with Cushing's syndrome. Chung Hua Ping Li Hsueh Tsa Chih 23:351-354, 1994.
8. Fukuda T, Kobayashi H, Kamishima T, et al.: Peripheral carcinoid tumor of the lung with focal melanin production. Pathol Int 44:309-316, 1994.
9. Yoshida J, Nagai K, Takahashi K, et al.: A rare case of typical carcinoid of the lung coincident with thymoma. Jpn J Clin Oncol 24:289-293, 1994.
10. Abbasciano V, Trevisani L, Sartori S: A case of a patient with multiple primary neoplasms: ileal leiomyosarcoma and bronchial carcinoid. Clin Ther 146:227-229, 1995.
11. Lai SL, Brauch H, Knutsen T, et al.: Molecular genetic characterization of neuroendocrine lung cancer cell lines. Anticancer Res 15:225-232, 1995.
12. Miller RR, Muller NL: Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumors. Am J Surg Pathol 19:653-658, 1995.
13. Marty-Ane CH, Costes V, Pujol JL, et al.: Carcinoid tumors of the lung: do atypical features require aggressive management? Ann Thorac Surg 59:78-83, 1995.
14. Kayser K, Bovin NV, Korchagina EY, et al.: Correlation of expression of binding sites for synthetic blood group A-, B-, and H-trisaccharides and for sarcolectin with survival of patients with bronchial carcinoma. Eur J Cancer 30A:653-657, 1994.
15. Gabius HJ, Kayser K, Gabius S: Protein-Zucker-Erkennung. Grundlagen und medizinische Anwendung am Beispiel der Tumorlektinologie. Naturwissenschaften 82:533-543, 1995.
16. Kayser K, Bovin NV, Zeng FY, et al.: Binding capacities to blood group antigen A, B, and H, DNA- and MST measurements, and survival in bronchial carcinoma. Radiol Oncol 28:282-286, 1994.
17. Kohnke-Godt B, Gabius HJ: Heparin-binding lectin from human placenta: purification, partial molecular characterization and its relationship to basic fibroblast growth factors. Biochemistry 28:6531-6538, 1989.
18. Kohnke-Godt B, Gabius HJ: Heparin-binding lectin from human placenta: further characterization of ligand binding and structural properties and its relationship to histones and heparin-binding growth factors. Biochemistry 30:55-65, 1991.
19. Wang DC, Johnston CF, Anderson N, et al.: Overexpression of the tumor suppressor gene p53 is not implicated in neuroendocrine tumour carcinogenesis. J Pathol 175:397-401, 1995.
20. Lohmann DR, Fesseler B, Putz B, et al.: Infrequent mutations of the p53 gene in pulmonary carcinoid tumors. Cancer Res 53:5797-5801, 1993.
21. World Health Organization (WHO): "Histological Classification of Lung Tumors." Geneva, 1981.
22. International Union against Cancer (UICC), Spiessl B, Beahrs, OH, Hermanek P, Hutter RVP, Scheibe O, Sobin LH, Wagner G (eds): " TNM Atlas," 2nd ed. Heidelberg; Springer, 1990.
23. Danguy A, Kayser K, Bovin NV, Gabius HJ: The relevance of neoglycoconjugates for histology and pathology. Trends Glycosci Glycotechnol 7:261-275, 1995.
24. a trisaccharide with polymers by the oligosaccharide-glycosylated-spacer antigen. Soviet J Bio-organ Chem 11:362-370, 1985.
25. Kayser K, Heil M, Gabius HJ: Is the profile of binding of a panel of neoglycoproteins useful as a diagnostic marker in human lung cancer? Pathol Res Pract 184:621-629, 1989.
26. Zeng FY, Weisser WY, Kratzin H, et al.: The major binding protein of the interferon antagonist sarcolectin in human placenta is a macrophage migration inhibitory factor. Arch Biochem Biophys 303:74-80, 1993.
27. Gabius HJ, Kohnke-Godt B, Leichsenring M, Bardosi A: Heparin-binding lectin from human placenta as a tool for histochemical ligand localization and isolation. J Histochem Cytochem 39:1249-1256, 1991.
28. Mikel UV, Fishbein WN, Bahr GF: Some practical considerations in quantitative absorbance microspectrophotometry. Analyt Quant Cytol Histol 7:107-118, 1985.
29. Schulte E, Böcking A: Standardization of the Feulgen reaction including a quality assurance protocol for diagnostic DNA image cytometry. Electron J Pathol Histol 954-04, 1995.
30. Haroske G, Meyer WD, Theissig F, Kunze KD: Optical limitations for precision and accuracy of DNA image cytometry. Electron J Pathol Histol 954-05, 1995.
31. Stenkvist B, Strande G: Entropy as an algorithm for the statistical descripton of DNA cytometric data obtained from image analysis microscopy. Anacel 2:159-166, 1990.
32. Kayser K, Kremer K, Tacke M: Integrated optical density and Entropiefluss (current of entropy) in bronchial carcinoma. In Vivo 7:387-391, 1993.
33. Kayser K, Stute H, Tacke M: Minimum spanning tree, integrated optical density and lymph node metastasis in bronchial carcinoma. Anal Cell Pathol 5:225-234, 1993.
34. Kaplan EL, Meier P: Nonparametric estimations from incomplete observations. Am Stat Assoc J 53:457-481, 1953.
35. Valli M, Fabris GA, Dewar A, et al.: Atypical carcinoid tumour of the lung: a study of 33 cases with prognostic features. Histopathology 24:363-369, 1994.
36. Smolle-Juttner FM, Popper H, Kiemen H, et al.: Clinical features and therapy of "typical" and "atypical" bronchial carcinoid tumors (grade 1 and grade 3 neuroendocrine carcinoma). Eur J Cardiothorac Surg 7:121-124; discussion p. 125, 1993.
37. Vadasz P, Palffy G, Egervary M, Schaff Z: Diagnosis and treatment of bronchial carcinoid tumors: Clinical and pathological review of 120 operated patients. Eur J Cardiothorac Surg 7:8-11, 1993.
38. Roncalli M, Doglioni C, Springall DR, et al.: Abnormal p53 expression in lung neuroendocrine tumors: Diagnostic and prognostic implications. Diagn Mol Pathol 1:129-135, 1992.
39. Costes V, Marty-Ane C, Picot MC, et al.: Typical and atypical bronchopulmonary carcinoid tumors: a clinicopathologic and Ki 67-labeling study. Hum Pathol 26:740-745, 1995.
40. Kayser K, Jacinto SD, Boehm G, et al.: Application of computer-assisted morphometry to the analysis of prenatal development of human lung. Anat Histol Embryol, 1996 (in press).
41. Schreurs AJ, Westermann CJ, van den Bosch JM, et al.: A twentyfive-year follow-up of ninety-three resected typical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 104:1470-1475, 1992.
42. Gabius HJ, Kayser K: Elucidation of similarities of sugar receptor (lectin) expression of human lung metastases from histogenetically different types of primary tumors. Anticancer Res 9:1599-1604, 1989.
43. Gabius S, Schirrmacher V, Franz H, et al.: Analysis of cell surface sugar receptor expression by neoglycoenzyme binding and adhesion to plastic-immobilized neoglycoproteins for related weakly and strongly metastatic cell lines of murine tumor model systems. Im J Cancer 46:500-507, 1990.
44. Gabius HJ, Gabius S (eds): "Lectins and Glycobiology." Heidelberg: Springer, 1993.
45. Gabius HJ, Gabius S (eds): "Glycosciences: Status and Perspectives." Weinheim: Chapman & Hall, 1996.